METALINEAR

metaLinear focuses on the identification and validation of new drug targets for difficult to treat bacterial infections. metaLinear uses a proprietary proteome engineering platform technology to uncover, characterise and validate new targets for antibiotics. Using very large libraries of Randomised proteins (R-teins) expressed in target bacteria, metaLinear will screen for novel targets responsible for the desired phenotype. A key advantage of this approach is the ability to de-risk targets and hence provide multiple efficiency gains in the traditional target and drug discovery process.

#SimilarOrganizations #People #Financial #Website #More

METALINEAR

Industry:

Biotechnology Health Care Medical

Founded:

2017-01-01

Address:

Alderley Edge, Cheshire, United Kingdom

Country:

United Kingdom

Website Url:

http://www.metalinear.co.uk

Total Employee:

Status:

Active

Email Addresses:

[email protected]

Total Funding:

255 K GBP

Technology used in webpage:

SPF Microsoft Exchange Online Office 365 Mail

Similar Organizations

acthera-therapeutics-logo

Acthera Therapeutics

Acthera Therapeutics is developing an innovative nanotechnology-based platform for the controlled and targeted drug delivery

xrapid-logo

xRapid

xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence.

Current Employees Featured

claire-brown_image

Claire Brown
Claire Brown Investment Director @ metaLinear
Investment Director

paul-ko-ferrigno_image

Paul Ko Ferrigno
Paul Ko Ferrigno CEO @ metaLinear
CEO
2017-02-01

nel-moore_image

Nel Moore
Nel Moore Non Executive Director @ metaLinear
Non Executive Director

Founder

paul-ko-ferrigno_image

Paul Ko Ferrigno

Investors List

catapult-venture-managers_image

Official Site Inspections

http://www.metalinear.co.uk

Host Informations
Whois Informations

Loading ...